FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2520046479> ?p ?o ?g. }

• W2520046479 endingPage "863" @default.
• W2520046479 startingPage "859" @default.
• W2520046479 abstract "Abstract Background and Aim Sofosbuvir (SOF) was the first directly acting antiviral made available for chronic hepatitis C (CHC) in India. We describe our “real life” experience of using SOF with ribavirin (RBV) with or without pegylated interferon (Peg‐IFN) in predominant genotype 3 patients with CHC. Methods A total of 158 patients (men 99 [62.6%], mean age 40.3 ± 12.8 years) with CHC treated with dual therapy (SOF + RBV) for 24 weeks or triple therapy (Peg‐IFN + SOF + RBV) for 12 weeks were included prospectively. Patients with co‐infection, decompensated liver disease, and post‐organ transplantation were excluded. Data were analysed for the preference of treatment regimen, end of treatment response (ETR), sustained virological response at 12 weeks, and side effects. Results Genotype 3 was the predominant genotype (105 [66.4%]) followed by genotype 1 (40 [25.3%]) and genotype 4 (13[8.2%]). Forty‐eight (30.37%) patients had cirrhosis (LSM ≥ 13 kPa), and 30 (19%) were treatment experienced with Peg‐IFN + RBV. A total of 103 (65.18%) patients received dual therapy, and 55 (34.81%) received triple therapy. Resentment to receive injections, inaccessibility to a facility, fear of injection or its side effects, and financial constraints were the reasons to refuse triple therapy. All patients in triple therapy group and all but two patients (98%) in the dual therapy group attained ETR. All those who achieved ETR achieved sustained virological response at 12 weeks in both groups. But for anemia in three patients (two in triple, one in dual therapy), there were no major side effects. Conclusions Most patients with CHC prefer an oral treatment with directly acting antivirals. Both oral and interferon‐based regimens achieve high response rate." @default.
• W2520046479 created "2016-09-23" @default.
• W2520046479 creator A5026914699 @default.
• W2520046479 creator A5027620539 @default.
• W2520046479 creator A5038267980 @default.
• W2520046479 creator A5048552465 @default.
• W2520046479 creator A5086116099 @default.
• W2520046479 creator A5090656568 @default.
• W2520046479 date "2017-03-24" @default.
• W2520046479 modified "2023-10-03" @default.
• W2520046479 title "Dual treatment with sofosbuvir plus ribavirin is as effective as triple therapy with pegylated interferon plus sofosbuvir plus ribavirin in predominant genotype 3 patients with chronic hepatitis C" @default.
• W2520046479 cites W1557711811 @default.
• W2520046479 cites W1949789545 @default.
• W2520046479 cites W1977076145 @default.
• W2520046479 cites W2015857002 @default.
• W2520046479 cites W2042063943 @default.
• W2520046479 cites W2058283467 @default.
• W2520046479 cites W2062307261 @default.
• W2520046479 cites W2078251659 @default.
• W2520046479 cites W2082799940 @default.
• W2520046479 cites W2120010688 @default.
• W2520046479 cites W2125963799 @default.
• W2520046479 cites W2127548135 @default.
• W2520046479 cites W2129197666 @default.
• W2520046479 cites W2141769755 @default.
• W2520046479 cites W2142895379 @default.
• W2520046479 cites W2150652264 @default.
• W2520046479 cites W2158519211 @default.
• W2520046479 doi "https://doi.org/10.1111/jgh.13595" @default.
• W2520046479 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27624314" @default.
• W2520046479 hasPublicationYear "2017" @default.
• W2520046479 type Work @default.
• W2520046479 sameAs 2520046479 @default.
• W2520046479 citedByCount "21" @default.
• W2520046479 countsByYear W25200464792017 @default.
• W2520046479 countsByYear W25200464792018 @default.
• W2520046479 countsByYear W25200464792020 @default.
• W2520046479 countsByYear W25200464792023 @default.
• W2520046479 crossrefType "journal-article" @default.
• W2520046479 hasAuthorship W2520046479A5026914699 @default.
• W2520046479 hasAuthorship W2520046479A5027620539 @default.
• W2520046479 hasAuthorship W2520046479A5038267980 @default.
• W2520046479 hasAuthorship W2520046479A5048552465 @default.
• W2520046479 hasAuthorship W2520046479A5086116099 @default.
• W2520046479 hasAuthorship W2520046479A5090656568 @default.
• W2520046479 hasConcept C126322002 @default.
• W2520046479 hasConcept C203014093 @default.
• W2520046479 hasConcept C2522874641 @default.
• W2520046479 hasConcept C2776408679 @default.
• W2520046479 hasConcept C2776455275 @default.
• W2520046479 hasConcept C2776461080 @default.
• W2520046479 hasConcept C2777214474 @default.
• W2520046479 hasConcept C2778390639 @default.
• W2520046479 hasConcept C2780040827 @default.
• W2520046479 hasConcept C2781413609 @default.
• W2520046479 hasConcept C71924100 @default.
• W2520046479 hasConcept C90924648 @default.
• W2520046479 hasConceptScore W2520046479C126322002 @default.
• W2520046479 hasConceptScore W2520046479C203014093 @default.
• W2520046479 hasConceptScore W2520046479C2522874641 @default.
• W2520046479 hasConceptScore W2520046479C2776408679 @default.
• W2520046479 hasConceptScore W2520046479C2776455275 @default.
• W2520046479 hasConceptScore W2520046479C2776461080 @default.
• W2520046479 hasConceptScore W2520046479C2777214474 @default.
• W2520046479 hasConceptScore W2520046479C2778390639 @default.
• W2520046479 hasConceptScore W2520046479C2780040827 @default.
• W2520046479 hasConceptScore W2520046479C2781413609 @default.
• W2520046479 hasConceptScore W2520046479C71924100 @default.
• W2520046479 hasConceptScore W2520046479C90924648 @default.
• W2520046479 hasIssue "4" @default.
• W2520046479 hasLocation W25200464791 @default.
• W2520046479 hasLocation W25200464792 @default.
• W2520046479 hasOpenAccess W2520046479 @default.
• W2520046479 hasPrimaryLocation W25200464791 @default.
• W2520046479 hasRelatedWork W1481102184 @default.
• W2520046479 hasRelatedWork W2051833020 @default.
• W2520046479 hasRelatedWork W2114705120 @default.
• W2520046479 hasRelatedWork W2138093122 @default.
• W2520046479 hasRelatedWork W2161030888 @default.
• W2520046479 hasRelatedWork W2494553535 @default.
• W2520046479 hasRelatedWork W2601299485 @default.
• W2520046479 hasRelatedWork W2808328549 @default.
• W2520046479 hasRelatedWork W2980025725 @default.
• W2520046479 hasRelatedWork W3110716148 @default.
• W2520046479 hasVolume "32" @default.
• W2520046479 isParatext "false" @default.
• W2520046479 isRetracted "false" @default.
• W2520046479 magId "2520046479" @default.
• W2520046479 workType "article" @default.